Experience

Nutriventia

• India
• Wellness and Fitness Services
• 1 - 100 Employee

• Senior scientific group leader

  • Feb 2019 - Present



Ajanta Pharma Ltd

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Formulation Scientist

  • Dec 2015 - Feb 2019

  Design and Development of bioequivalent formulations for US market (ANDA) and ROW market.  Expert in application and use of DoE software (Factorial design, Response surface design, Optimal design, Mixture design and Combine design.) using Stat-Ease version 10.  To manage and guide group of 2-3 junior scientist for formulation & development by QbD approach and using DoE software.  To plan and execute different strategies with juniors to achieve stable and bioequivalent formulation.  To plan for trial and stability batches and to guide the juniors to execute batches. To compile results and to make right conclusion.  Have good experience in development of immediate release, modified release dosage forms (Tablets and Capsule).  To carry out literature and patent search, preformulation studies, reference product characterization and it’s reverse engineering.  Successfully developed and taken exhibit batches of delayed release formulation containing pellets.  Execution of optimization, scale up and exhibit batches and to prepare related documents for the same.  Preparation of technical documents (MFR, PDR etc) needed during the development and technology transfer. Show less



Ipca Laboratories Limited

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Research Scientist

  • Sep 2012 - Dec 2015



Famy Care Ltd., Mumbai

• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Formulation Scientist

  • Aug 2011 - Sep 2012



Micro Labs Ltd.

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Executive R&D formulation

  • Aug 2010 - Aug 2011

  Executive R&D formulation Executive R&D formulation



Okasa

• Mumbai Area, India

• Production Chemist

  • Aug 2010 - Jul 2011

  Executive R&D formulation Executive R&D formulation